Join to View Full Profile
615 Michael St NERm 105-BAtlanta, GA 30322
Phone+1 404-712-2805
Fax+1 404-727-8538
Dr. Jaye is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Emory University School of MedicineFellowship, Hematopathology, 1997 - 1998
University of Alabama Medical CenterResidency, Pathology-Anatomic and Clinical, 1995 - 1997
Washington University/B-JH/SLCH ConsortiumResidency, Pathology-Anatomic and Clinical, 1991 - 1995- Washington University in St. Louis School of MedicineClass of 1991
Certifications & Licensure
GA State Medical License 1997 - 2025
AL State Medical License 1995 - 1997
American Board of Pathology Anatomic Pathology & Clinical Pathology- American Board of Pathology Hematology
Publications & Presentations
PubMed
- 1 citationsHeme promotes venetoclax resistance in multiple myeloma through MEK-ERK signaling and purine biosynthesis.Remya Nair, An H Vu, Abigail K Freer, Karanpreet S Bhatia, Dongxue Wang
Blood. 2025-02-13 - Real-world impact of differences in the WHO and ICC classifications of non-Hodgkin lymphoma: a LEO cohort study analysis.Brooj Abro, Matthew J Maurer, Thomas M Habermann, W Richard Burack, Jennifer R Chapman
Blood. 2024-11-07 - The unnecessary use of short tandem repeat testing on bone marrow samples in patients after 1 year following allogeneic hematopoietic stem cell transplant.Anna B Morris, H Clifford Sullivan, Melanie S Wooten, Edmund K Waller, David L Jaye
American Journal of Clinical Pathology. 2024-11-04
Abstracts/Posters
- Utility and Patterns of Use of PET/CT and Bone Marrow Biopsy for Staging in Non-Hodgkin Lymphoma in the Clinical Setting: A Retrospective Analysis Using the LEO DatabaseDavid L. Jaye, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Whole Exome and Transcriptome Sequencing in 1042 Cases Reveals Distinct Clinically Relevant Genetic Subgroups of Follicular LymphomaDavid L. Jaye, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Vulnerable Elders Survey-13 (VES-13) Predicts 1-Year Mortality Risk in Newly Diagnosed Non-Hodgkin Lymphoma (NHL)David L. Jaye, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Lectures
- Outcomes of Myeloma Patients with Deletion 1p Receiving Lenalidomide, Bortezomib, and Dexamethasone (RVD) Therapy2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- The Lymphoma Epidemiology of Outcomes (LEO) Cohort Study Reflects the Demographics and Subtypes of Patients Diagnosed with Non-Hodgkin Lymphoma in the United States2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Press Mentions
'Treason' by Immune System Cells Aids Growth of Multiple MyelomaOctober 8th, 2009
Grant Support
- GI Inflammation: Novel G-Protein Coupled PMN ResponsesNational Institute Of Diabetes And Digestive And Kidney Diseases2002–2006
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
